Icodextrin: Clinical Trials

21 trials of Icodextrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 unknown, 3 terminated, 2 withdrawn. 8 Phase 4, 4 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 48Completed 6, Unknown 1, Withdrawn 1
Not applicable4Unknown 2, Completed 1, Terminated 1
Phase 23Completed 1, Terminated 1, Withdrawn 1
Phase 33Completed 2, Terminated 1
Phase 12Completed 1, Unknown 1

Follow Icodextrin: new trials by email Literature Review of Icodextrin trials Research Report on Icodextrin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of Single- and Double-dose Icodextrin
Icodextrin - Peritoneal Dialysis
Not applicableUnknownPeking University First Hospital162024-08-152024-08-14
Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients
Icodextrin Peritoneal Dialysis Solution, Glucose Peritoneal Dialysis Solution - Chronic Renal Failure
CompletedVantive Health LLC4392024-06-282026-04-15
The Difference Between Daily and Alternative Day Use of Icodextrin
Icodextrin Peritoneal Dialysis Solution - Peritoneal Dialysis Solution Adverse Reaction
Phase 4UnknownRenJi Hospital742023-08-012023-07-13
Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution
30% icodextrin and 10% dextrose - Chronic Kidney Diseases
Phase 1UnknownInstituto Mexicano del Seguro Social102023-02-032023-03-28
Icodextrin Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Solution in PD Patients
Icodextrin/Dextrose - Chronic Kidney Failure
Phase 1CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's102022-10-172024-01-29
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
Icodextrin, xylitol and carnitine solution for peritoneal dialysis, EXTRANEAL 7.5G/100Ml Peritoneal Dialysis Solution - End Stage Renal Disease (ESRD)
Phase 2WithdrawnIperboreal Pharma Srl2019-10-022024-10-01
Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients
Extraneal (Icodextrin), Glucose solution - End Stage Renal Disease
Not applicableCompletedDong-A University222014-06-012019-05-29
Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD.
Icodextrin - Renal Insufficiency
Phase 4CompletedPr Eric Goffin1172013-03-012020-11-10
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
Dianeal, Dianeal, Extraneal, Nutrineal - End Stage Renal Disease (ESRD), Diabetes
Phase 3CompletedVantive Health LLC712010-10-012025-07-24
Use of a Bimodal Solution for Peritoneal Dialysis
bimodal solution, icodextrin - End Stage Renal Disease
Phase 2CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's362010-09-302017-08-28
Peritoneal Dialysis in Congestive Heart Failure
icodextrin - Congestive Heart Failure
Phase 3TerminatedMartini Hospital Groningen262010-04-012019-08-16
Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis
Icodextrin, glucose-based peritoneal dialysate - Peritonitis
Phase 4CompletedChinese University of Hong Kong562010-01-012016-08-10
Does Icodextrin Reduce the Risk of Small Bowel Obstruction?
Surgery, Icodextrin - Surgical Adhesions
Not applicableUnknownUppsala University18082009-12-012020-03-31
Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients
icodextrin, Dianeal - Disorders Associated With Peritoneal Dialysis
Phase 4CompletedPontifícia Universidade Católica do Paraná602009-10-012014-10-01
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
Dianeal, Physioneal, Extraneal - ESRD, Diabetes
Phase 3CompletedVantive Health LLC432008-04-012025-07-22
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients
Physioneal, Dianeal, Extraneal - ESRD, Diabetes
Phase 4CompletedVantive Health LLC1372008-01-012025-07-22
Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis
DIANEAL, EXTRANEAL - End-stage Renal Disease (ESRD), Kidney Disease
Phase 4CompletedOttawa Hospital Research Institute502007-07-012021-03-15
Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution - Peritoneal Dialysis, Hypertriglyceridemia
Phase 4WithdrawnVantive Health LLC2006-11-012025-03-03
Heart Failure and Peritoneal Ultrafiltration
Extraneal - Congestive Heart Failure
Phase 2TerminatedVantive Health LLC122006-08-012025-07-15
Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis
Icodextrin (dialysate), Physioneal (dialysate) 1.36% and 2.27% - Peritoneal Dialysis
Not applicableTerminatedUniversity of Aarhus152006-01-012008-12-08

Showing 20 of 21. Sign in to see all of them.

Conditions studied

Kidney Failure, Chronic (10)  ·  Diabetes Mellitus (3)  ·  Heart Failure (2)  ·  Renal Insufficiency, Chronic (2)  ·  Colorectal Neoplasms (1)  ·  Diabetes Insipidus (1)  ·  Hypertriglyceridemia (1)  ·  Kidney Diseases (1)  ·  Peritonitis (1)  ·  Renal Insufficiency (1)  ·  Tissue Adhesions (1)

Sponsors

Vantive Health LLC (6)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2)  ·  Chinese University of Hong Kong (1)  ·  Dong-A University (1)  ·  Instituto Mexicano del Seguro Social (1)  ·  Iperboreal Pharma Srl (1)  ·  Martini Hospital Groningen (1)  ·  Ottawa Hospital Research Institute (1)  ·  Peking University First Hospital (1)  ·  Pontifícia Universidade Católica do Paraná (1)  ·  Pr Eric Goffin (1)  ·  RenJi Hospital (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  University of Aarhus (1)  ·  Uppsala University (1)

Countries

Canada (5)  ·  Australia (2)  ·  Belgium (2)  ·  China (2)  ·  Hong Kong (2)  ·  South Korea (2)  ·  United States (2)  ·  Brazil (1)  ·  Colombia (1)  ·  Denmark (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Singapore (1)

Top investigators

Arsh K Jain, MD (1)  ·  Christopher W McIntyre, MD/PHD (1)  ·  Eric Goffin (1)  ·  Jiaqi Qian, MD (1)  ·  Jie Dong, Professor (1)  ·  Juan B Ivey Miranda, MD (1)  ·  Marcel Ruzicka, MD, PhD (1)  ·  Mario Bonomini, MD (1)  ·  Per Ivarsen (1)  ·  Roberto Pecoits-Filho, MD, PhD (1)  ·  Urban Karlbom, PhD (1)

Results publications

PMID 24578470, PMID 26934850, PMID 37616463, PMID 39790231

NIH funding

2009 (1)